U.S. Industry Preps Proposals To Unseat Japanese Foreign Reference Pricing
This article was originally published in The Gray Sheet
Executive Summary
A group of U.S. medical device manufacturers is working to ensure that potential revisions to Japan's Pharmaceutical Affairs Law do not increase approval times for new products
You may also be interested in...
“New Phase” Of Japanese Health Care Opens Door To U.S. Manufacturers
A potential increase in the percentage of health care services paid for "out of pocket" by Japanese citizens will increase opportunities for the U.S. device industry to shape reforms of the country's health system, the Department of Commerce says
“New Phase” Of Japanese Health Care Opens Door To U.S. Manufacturers
A potential increase in the percentage of health care services paid for "out of pocket" by Japanese citizens will increase opportunities for the U.S. device industry to shape reforms of the country's health system, the Department of Commerce says
Established Firms Have Most To Gain From Japanese Device Revisions
Members of the Japanese Ministry of Health, Labor and Welfare are meeting with notified bodies (NBs) in the UK to better understand how elements of the European regulatory system would apply in Japan